Table 3.
Clinicopathological factors by histopathological phenotype.
| Characteristics | Intestinal type | Gastric type | Pancreatobiliary type | p† | p†† |
|---|---|---|---|---|---|
| (n = 97) | (n = 37) | (n = 54) | |||
| Mean age (years) | 59.7 (58–61.3) | 61.1 (57.8–64.4) | 61.6 (59.5–63.8) | 0.38 | 0.18 |
| Gender | 0.42 | 1 | |||
| F | 60 (61.9%) | 26 (70.3%) | 33 (61.1%) | ||
| M | 37 (38.1%) | 11 (29.7%) | 21 (38.9%) | ||
| Tumor size (cm) | 0.70 | 0.74 | |||
| <3 cm | 55 (56.7%) | 23 (62.2%) | 29 (53.7%) | ||
| >3 cm | 42 (43.3%) | 14 (37.8%) | 25 (46.3%) | ||
| Histologic grade | 0.70 | 0.61 | |||
| Well or moderately differentiated | 46 (42.1%) | 19(45.2%) | 28 (59.4%) | ||
| Low or poorly differentiated | 51 (57.9%) | 18 (54.8) | 26 (40.6%) | ||
| LN status | 0.11 | 0.004 | |||
| Positive | 18 (19.3%) | 12 (27.4%) | 22 (34.8%) | ||
| Negative | 79 (80.7%) | 25 (72.6%) | 32 (65.2%) | ||
| Margin status | 0.15 | 1 | |||
| Negative | 82 (87.8%) | 35 (94.6%) | 46 (85.6%) | ||
| Positive | 15 (12.2%) | 2 (5.4%) | 8 (14.4%) | ||
| Perineural invasion | 0.34 | 0.53 | |||
| Present | 18 (10.5%) | 10 (45.2%) | 13 (10.1%) | ||
| Not present | 79 (89.5%) | 27 (54.8%) | 41 (89.9%) | ||
| TNM stage | 0.56 | 0.089 | |||
| I to II stage | 58 (59.8%) | 20 (54.1%) | 24 (44.4%) | ||
| III to IV stage | 39 (40.2%) | 17 (45.9%) | 30 (55.6%) | ||
| Surgery procedure | 0.02 | 0.007 | |||
| Radical resection | 91 (93.8%) | 29 (78.3%) | 42 (77.8%) | ||
| Palliative care | 6 (6.2%) | 8 (21.7%) | 12 (22.2%) | ||
| Adjuvant treatmen | 0.698 | 0.498 | |||
| Yes | 53 (54.6%) | 22 (59.5%) | 26 (48.1%) | ||
| No | 44 (45.4%) | 15 (40.5%) | 28 (51.9%) |
F, female; M, male.
†p comparison between non-ampullary duodenal carcinoma and ampullary carcinoma.
††p comparison between non-ampullary duodenal carcinoma and duodenal papillary adenocarcinomas.